PDIK1L and cancer: Mechanistically, PDIK1L’s interaction with nucleotide biosynthesis pathways could deplete dNTP pools, exacerbating replication stress and genomic instability in C2 tumors—a phenomenon observed in BRCA1-deficient cancers treated with PARPi (Mateo et al., 2015).